Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.15, $0.04 better than the analyst estimate of $5.11. Revenue for the quarter came in at $10.36 billion versus the consensus estimate of $10.23 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.